Controversy surrounds landmark anti-platelet drug trial

An investigation published by The BMJ today raises new concerns over the landmark clinical trial (PLATO) that was used to gain worldwide approval for the anti-platelet drug ticagrelor (Brilinta in the US and Brilique in Europe), manufactured by AstraZeneca.

Direct to consumer channels change patient-healthcare system relationship – Pharmaceutical Technology

From left to right: moderator Oliver Barnes, US Pharmaceutical and Biotech Correspondent, Financial Times; Eden Wells, Chief Insights and Decision Science Officer, Novartis; Amy West,

May 20, 2024

Early detection of cardiovascular diseases using advanced machine learning

How can diseases of the cardiovascular system be detected before symptoms appear? Researchers at Graz University of Technology (TU Graz) have found a way to

August 13, 2024

What Medicare Advantage Changes Would a Trump or Harris Administration Make?

Policy experts and former health officials cast their predictions on what health policy changes to expect from the next administration during an online panel discussion

August 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.